Trademark: 97231957
Word
EPIVAX THERAPEUTICS
Status
Pending
Status Code
819
Status Date
Tuesday, February 13, 2024
Serial Number
97231957
Mark Type
4000
Filing Date
Friday, January 21, 2022
Published for Opposition
Tuesday, December 6, 2022

Trademark Owner History
EpiVax, Inc. - Owner At Publication

Classifications
42 Research and development of vaccines and medicines; Pharmaceutical research and development; Vaccine research and development
"THERAPEUTICS"

Trademark Events
Feb 16, 2024
On Hold - Electronic Record Review Required
Feb 14, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 13, 2024
Allowed Principal Register - Sou Accepted
Feb 8, 2024
Statement Of Use Processing Complete
Jan 18, 2024
Use Amendment Filed
Feb 8, 2024
Case Assigned To Intent To Use Paralegal
Jan 18, 2024
Teas Statement Of Use Received
Jun 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 22, 2023
Sou Extension 1 Granted
Jun 22, 2023
Sou Extension 1 Filed
Jun 22, 2023
Sou Teas Extension Received
Jan 31, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 3, 2022
Approved For Pub - Principal Register
Nov 2, 2022
Teas/Email Correspondence Entered
Nov 1, 2022
Correspondence Received In Law Office
Nov 1, 2022
Teas Response To Office Action Received
Nov 1, 2022
Notification Of Non-Final Action E-Mailed
Nov 1, 2022
Non-Final Action E-Mailed
Nov 1, 2022
Non-Final Action Written
Nov 1, 2022
Assigned To Examiner
Sep 21, 2022
Teas Change Of Correspondence Received
Sep 21, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 21, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 26, 2022
New Application Office Supplied Data Entered
Jan 25, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24